Nusantara Bioscience has agreed to follow the ethical
standards as determined by the Committee on
Publication Ethics (COPE) as well as
International Committee of
Medical Journal Editors (ICMJE).
Author(s) must obedient and pay attention to the authorship,
plagiarism, duplicate (redundant) publication, fabrication
of data, manipulation of citation, as well as ethical
approval and Intelectual Property Rights.
Author is a person who participated in the
research and sufficient for taking public responsibility for
all portions of the content. When authorship is attributed
to a group, all authors should have made substantial
contributions to the following: (i) conception and design of
the research, acquisition of the data, analysis and interpretation of
the data; (ii) drafting of the manuscript and its revision;
and (iii) final approval of the version to be submitted.
implies that all
authors have read
and approved the
of the manuscript,
submission to this
All authors must be responsible for the
quality, accuracy, and ethics of the research.
Plagiarism is the practice of taking someone else's work or ideas and
passing them off as one's own.
Submitted manuscripts should be the original works of the
Duplicate (redundant) publication
Duplicate publication is publication of a paper that
overlaps substantially with one already published, without
clear, visible reference to the previous publication.
Manuscript submissions will be considered for publication
only if they are submitted solely to this journal and do not
overlap substantially with a published article. Any
manuscript that has (near) similar hypothesis, sample
characteristics, methodology, results, and conclusions to a
published article is a duplicate article
and is prohibited,
in different languages.
of data from
should be avoided.
Fabrication of data
Fabrication, manipulation or falsification of data is an
ethical violation and is prohibited.
The only relevant citations are used in the
manuscripts. Irrelevant (self) citation to increase
author(s)'s citation (h-index) or unnecessary citation to improve the
references are not allowed.
Experiments held on human and animals
must obtain permission
from the official
does not violate
Human or animal related experiments should be published in
"Materials and Methods", then examined and got approved by
professionals from the side of moral aspect. Researches on
human beings must comply with the principles of the
Declaration of Helsinki and its recommendations guiding
physicians in biomedical research involving human subjects.
Human details may be included only if they are essential for
scientific purposes and the author(s) obtain written
from the individual,
Intellectual Property Right
Author(s) must obedient to the law and/or
ethics in treating the object of research and pay attention
to the legality of material sources and intellectual
Conflict of interest and source of funding
requires to acknowledge all sources of institutional,
private and corporate financial support for the research
within the manuscript, and notes any potential conflicts of
The acceptance of a paper implies
that it has been reviewed and recommended by at least two
reviewers, one of whom is usually from the Editorial
Advisory Board. Authors will generally be notified of
acceptance, rejection, or need for revision within 2 to 3
months of receipt. Manuscript is rejected, if the content is
not in line with the journal scope, does not meet the
ethical standards (i.e. false authorship, plagiarism,
duplicate publication, fabrication of data and citation
manipulation), does not meet the required quality, written
in inappropriate format, has incorrect grammar, or ignores
correspondence in three months. Manuscripts can also be
rejected if there are two reviewers who gave a negative
note. The primary criteria for publication are scientific
quality and biological or natural conservation significance.
The accepted papers will be published in a chronological
order. This journal is published in January, April, July,
and October (starting on January 2017). However, online
publication was done immediately after acceptance.
The review process conducted
double blind, where the identity of authors and
reviewers are concealed.
Information on their identity can only be granted with the
consent of both sides. Authors are asked to propose a list
of 5-10 names of prospective reviewers. Management may
choose to invite them or not. Authors can also propose that
someone does not review. Reviewers must have the
Researcher-ID (Thomson Reuters)
or recorded as a corresponding author in
this journal. Reviewers may also be invited from journals
published by major publishers such as
They must come from different institutions with authors;
preferably originating from three different countries.
Basically, one can only review once a year.
List of the reviewer updated on every middle and end of
the year. Therefore, the reviewers in the past year could
not be invited; while the Editorial Advisory Board can only
be invited by management.
Uncorrected proofs will
be sent to the corresponding author by email as .doc
or .rtf (not
files for checking and correcting of
typographical errors. To avoid delay in publication,
corrected proofs should be returned in 7 days. The accepted
papers will be published online in a chronological order at
any time, but printed in January, April, July, and October.
of a manuscript implies that the submitted work has not been
published before (except as part of a thesis or report, or
abstract); that it is not under consideration for
publication elsewhere; that its publication has been
approved by all co-authors. If and when the manuscript is
accepted for publication, the author(s) still hold the
copyright and retain publishing rights without restrictions. Authors or others are allowed
to multiply article as long as not for commercial purposes.
For the new invention, authors are suggested to manage its
patent before published.
journal is committed to free-open access that does not
charge readers or their institutions for access. Readers are
entitled to read, download, copy, distribute, print, search,
or link to the full texts of articles, as long as not for
commercial purposes. The license type is CC-BY-NC-SA.
No responsibility is assumed by publisher and co-publishers,
nor by the editors for any injury and/or damage to persons
or property as a result of any actual or alleged libelous
statements, infringement of intellectual pro-perty or
privacy rights, or products liability, whether resulting
from negligence or otherwise, or from any use or operation
of any ideas, instructions, procedures, products or methods
contained in the material therein.